In a video interview, William K. Oh, MD, director of precision medicine at Yale Cancer Center and Smilow Cancer Hospital discusses the latest breakthroughs in advanced prostate cancer treatment.

In a video interview, William K. Oh, MD, director of precision medicine at Yale Cancer Center and Smilow Cancer Hospital discusses the latest breakthroughs in advanced prostate cancer treatment.

Dr. Jonathan R. Strosberg, discussed results of the CABINET trial evaluating Cabometyx versus placebo in advanced ...

Doctors are using AI to help diagnose and document, and patients like Rosen are leveraging its powers. In fact, one in six ...

According to research, PSAT1, PSRC1, COLEC12, HP, and PLLP may play a role in small cell lung cancer metabolism, immune ...

ITM announces positive Phase 3 results for ITM-11 in neuroendocrine tumours, paving the way for a potential new treatment ...

Gigi Moore’s tumor is caused by Zollinger-Ellison Syndrome, a rare cancer mostly found in men over 50. Since her diagnosis, James has been right by her side.

UCLA Health’s Outpatient Theranostics Center allows clinicians to treat up to 16 patients per day with Pluvicto and other ...

The Endocrine Society and the European Society of Endocrinology (ESE) are delighted to announce Professor Ashley Grossman, F.Med.Sci., as the winner of the 2025 Transatlantic Alliance Award.

The first patient has been dosed in a phase 1 dose-finding clinical trial evaluating iadademstat with Vidaza in patients with ...

Some people use Zollinger-Ellison syndrome and gastrinoma interchangeably. Learn the similarities and differences between the ...

Aaron Rejino and loyal Rejino Barbeque customers mourned the loss of Christina Rejino. The co-owner passed away on Jan. 14 ...